Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 3,617.45
+59.45 (1.67%)
At close: Sep 30, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 444.46 billion as of September 29, 2026. Its market cap has increased by 46.78% in one year.
Market Cap
444.46B
Enterprise Value
440.49B
Revenue
57.76B
Ranking
n/a
PE Ratio
39.16
Stock Price
3,617.45
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 444.46B, an increase of 78,454.59%. That is a compound annual growth rate of 31.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 444.46B | 28.53% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.90T |
| Dr. Reddy's Laboratories | 1.00T |
| Lupin | 955.62B |
| Abbott India | 572.37B |
| GlaxoSmithKline Pharmaceuticals | 477.19B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 215.92B |
| Caplin Point Laboratories | 215.55B |